Premier Fund Managers LTD Accelerate Diagnostics, Inc Transaction History

Premier Fund Managers LTD

  • $2.49 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 10, 2021
SELL
$7.99 - $15.0 $401,417 - $753,600
-50,240 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$9.98 - $18.04 $715,166 - $1.29 Million
-71,660 Reduced 58.79%
50,240 $542,000
Q2 2020

Aug 13, 2020
BUY
$7.49 - $15.16 $913,031 - $1.85 Million
121,900 New
121,900 $1.85 Million

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Premier Fund Managers LTD Portfolio

Follow Premier Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Premier Fund Managers LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email